VBCa

Private equity groups, MSOs, and growing physician organizations often acquire practices for a reason that doesn’t show up in the valuation model: access to the payer contracts the practice already holds. On paper, it looks like a shortcut around a contracting process that can take a year or more. In practice, the contract you paid for may not survive the transaction.

This article covers how acquirers typically think about practice targets, and then focuses on the part most deal teams underestimate: the assignment and change-in-control provisions in payer agreements.

Platform practices and add-ons

Most roll-up strategies start with a platform practice: a well-run group with the management, infrastructure, and market position to serve as the base for growth. Add-on practices are smaller acquisitions folded into the platform afterward to expand geography, specialty mix, or service lines. The platform is bought for its operating capability; add-ons are bought to scale it.

What makes a specialty attractive to investors

Investors gravitate toward markets that are highly fragmented, where the competitive landscape is shifting, where practice leadership is under-resourced, and where individual groups lack scale and access to capital. Those conditions create room for consolidation to add value through shared infrastructure, purchasing power, and stronger negotiating leverage with payers.

Selecting add-on practices

Strong add-on candidates tend to share a common profile. Each criterion below matters because it either protects the investment or makes the combined organization worth more than its parts.

• A defensible market position. A unique local opportunity, scarcity value, or a referral base competitors can’t easily replicate.
• Solid financials with room to grow. Strong revenue, earnings, and cash flow, plus a credible path to accelerating them.
• Aligned leadership. A capable management team with an equity stake, so physician leaders benefit from the same outcomes as investors.
• A scalable operating model. Processes and systems that can absorb growth in the current market and support expansion into new ones.
• Readiness for risk. The ability to take on and manage value-based or capitated arrangements as contracts evolve.
• Durable patient and customer relationships. Loyalty that survives a change in ownership.

Practice characteristics acquirers look for

Beyond the add-on profile, acquirers screen for features that expand revenue or reduce cost after closing:

• Revenue beyond physician services, such as diagnostics, imaging, and other ancillaries, or the potential to add them (screening mammography and laboratory services are common examples).
• Services delivered by allied professionals, which extend capacity without proportional physician cost.
• Exclusive or long-term professional services agreements that make revenue more predictable.
• Significant purchasing needs, such as oncology drugs, where consolidated buying power produces real savings.
• Long-term demand, particularly specialties that will see rising utilization as the Baby Boomer population ages.
• Scalability, meaning identifiable add-on targets and room to manage risk through better practice performance.
• Post-transaction physician compensation, since whether owner pay rises or falls after closing affects both retention and returns.

What moves the multiple

Four factors most consistently push valuation multiples up: favorable geography, demonstrated growth, larger size, and established ancillary revenue. A practice with all four will command a meaningfully higher price than one with none.

The contract-access trap: assignment and change in control

Here is where many acquisition strategies run into trouble. If a major reason for the deal is gaining access to the target’s payer contracts, the contracts themselves may prevent it.

Payer agreements commonly prohibit assigning the rights and obligations of the agreement to another party without the payer’s written consent. Many payers apply the same restriction to subcontracting any obligation under the agreement.

Change-in-control language goes further. These provisions often state that any transfer of ownership, in whole or in part, including the sale or transfer of shares or partnership interests, subjects the agreement to immediate termination unless the payer has approved it in writing. Some payers reserve the right to release themselves from their obligations under the agreement retroactively. Those obligations include claims payment.

The practical result: an acquirer can pay a substantial premium for a practice, close the deal, and then learn that the contract it was counting on has been terminated, with past claims potentially at risk.

Three provisions deserve the closest scrutiny:

1. Assignment. Without proper written approval, an acquired contract can be terminated, potentially retroactively.
2. Change in control. Same exposure, triggered by the ownership change itself rather than a formal assignment.
3. Rates. Even if the contract survives, the rates may not support the economics of the deal, forcing renegotiation.

What the contract audit has to answer

Before relying on acquired contracts, the acquirer needs a contract audit and risk assessment. At minimum, it should answer:

• Does the practice have valid copies of the base agreement, every amendment (mutual and unilateral), and the fee schedules currently in effect? Many practices do not have these ready, and confirming completeness with the payer takes time.
• What do the notice, term and termination, assignment, and change-in-control provisions actually require?
• How much notice must be given to the payer, and through what channel?
• How long does the payer have to approve or deny, and what options does it hold if it refuses, including termination?

How long it realistically takes

Timelines vary by payer and by how organized the practice’s records are, but these ranges are typical:

In other words, an acquirer may wait a year to learn whether the contracts it paid for will hold.

What to do instead

Treat acquired contracts as upside, not as the plan. The most reliable approach is to pursue your own payer contracts in parallel with any acquisition, so the organization isn’t dependent on a payer’s approval to keep revenue flowing. In addition:

• Run the contract audit before signing, not after closing.
• Price the risk of contract loss into the deal, and consider protections such as escrows, holdbacks, or closing conditions tied to payer consent.
• Model the operational cost of a gap in network participation, including cash flow and the cost of re-enrollment.

A note on joint contracting and antitrust

Organizations sometimes consider joint contracting among independent practices as an alternative to outright acquisition. Independent health care professionals who negotiate fees jointly must demonstrate sufficient financial or clinical integration to satisfy antitrust enforcement agencies. Without that integration, joint fee negotiation can be treated as price-fixing.

This article is for general informational purposes only and is not legal, financial, or tax advice. Contract terms vary by payer and agreement; consult qualified counsel before relying on any acquired agreement.